Acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsu... — RxCUI 2377385
RxNorm drug concept · Semantic clinical drug
RxCUI 2377385
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2377385
Official nameAcetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule; acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
- Why am I getting acetaminophen through an IV instead of just taking a pill?
- Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
- The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
🕸️ Concept Web — How Acetaminophen 325 MG / dextromethorphan hydrobro... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
RxCUI 2377385 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Dextromethorphan
3289IN -
Guaifenesin
5032IN -
Acetaminophen / dextromethorphan / guaifenesin
689775MIN -
Dextromethorphan hydrobromide
102490PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / dextromethorphan / guaifenesin Oral Capsule
2377384SCDF -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Capsule
2648508SCDFP -
Acetaminophen / dextromethorphan / guaifenesin Oral Product
1155913SCDG -
Acetaminophen / dextromethorphan / guaifenesin Pill
1155914SCDG -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Product
2662330SCDGP -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Pill
2662448SCDGP -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Acetaminophen / dextromethorphan / guaifenesin Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 325 MG
315263SCDC -
Dextromethorphan hydrobromide 10 MG
1014455SCDC -
Guaifenesin 200 MG
317384SCDC
-
Acetaminophen 325 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 325 MG
SCDC · 315263 -
Dextromethorphan hydrobromide 10 MG
SCDC · 1014455 -
Guaifenesin 200 MG
SCDC · 317384 -
Acetaminophen / dextromethorphan / guaifenesin Oral Capsule
SCDF · 2377384 -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Capsule
SCDFP · 2648508 -
Acetaminophen / dextromethorphan / guaifenesin Oral Product
SCDG · 1155913 -
Acetaminophen / dextromethorphan / guaifenesin Pill
SCDG · 1155914 -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Oral Product
SCDGP · 2662330 -
Acetaminophen / dextromethorphan hydrobromide / guaifenesin Pill
SCDGP · 2662448
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 2377385 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 11673-0844-24 | 24 BLISTER PACK in 1 CARTON (11673-844-24) / 1 KIT in 1 BLI... | Daytime Nighttime Severe Cold and Flu | TARGET CORP | 2024-07-01 |
| 35916-0184-02 | 3000 CAPSULE, LIQUID FILLED in 1 POUCH (35916-0184-2) | Acetaminophen, Dextromethorphan HBr ,Guaifenesin | Softgel Healthcare Pvt Ltd | 2025-05-17 |
| 35916-0184-03 | 2 POUCH in 1 BOX (35916-0184-3) / 2000 CAPSULE, LIQUID FILL... | Acetaminophen, Dextromethorphan HBr ,Guaifenesin | Softgel Healthcare Pvt Ltd | 2025-09-25 |
| 35916-0184-04 | 2 BAG in 1 BOX (35916-0184-4) / 1500 CAPSULE, LIQUID FILLED... | Acetaminophen, Dextromethorphan HBr ,Guaifenesin | Softgel Healthcare Pvt Ltd | 2026-01-16 |
Observed labelers:
Softgel Healthcare Pvt Ltd (3) ·
TARGET CORP (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.